Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00859950 · ClinicalTrials.gov registry record · NA

Mechanisms of Endothelial Cell Dysfunction in Sleep Apnea

A NA study, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
NA
Development phase
70
Enrollment target

NCT00859950 is a NA study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 70 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00859950, a NA study, has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
NA
Development phase
70 participants
Enrollment target

Study Summary

Sleep apnea is a common sleep disorder characterized by temporary stops in breathing during sleep and has been associated with the development of cardiovascular disease. This research will investigate one potential mechanism leading to the development of cardiovascular disorder, specifically, the blockage of blood vessels called "vascular occlusion", in subjects with sleep apnea. A group of healthy controls will be used for comparison. All subjects will undergo clinical evaluation followed by an overnight sleep study and a morning blood draw. Subjects with sleep apnea will be treated according to standard clinical management and followed under the research protocol for one month. At the end of one month, a repeat blood draw will be performed on the sleep apnea subjects for comparative analysis. If a control subject is found to have any abnormality during this research study, he or she will be referred for further clinical evaluation.

Interventions

  • DEVICE Continuous Positive Airway Pressure (CPAP)

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2009-04
Est. Completion 2015-08
Phase NA

What the Registry Record Tells You About NCT00859950

The ClinicalTrials.gov registry entry for NCT00859950 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Continuous Positive Airway Pressure (CPAP) is the first listed.

NCT00859950 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00859950 about?

NCT00859950 is a clinical study titled "Mechanisms of Endothelial Cell Dysfunction in Sleep Apnea". Sleep apnea is a common sleep disorder characterized by temporary stops in breathing during sleep and has been associated with the development of cardiovascular disease. This research will investigate one potential mechanism leading to the development of cardiovascular disorder, specifically, the bl...

What is the current status of trial NCT00859950?

This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2009-04. Estimated completion is 2015-08.

What interventions are being tested in trial NCT00859950?

The interventions under investigation include: Continuous Positive Airway Pressure (CPAP) (DEVICE).

Who is sponsoring clinical trial NCT00859950?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.